- Home
- MRK vs MNTSW Comparison
MRK vs MNTSW Comparison
Compare MRK & MNTSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRK | MNTSW |
|---|---|---|
| Founded | 2000 | N/A |
| Country | United States | United States |
| Employees | N/A | 123 |
| Industry | Biotechnology: Pharmaceutical Preparations | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 260.2B | N/A |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | MRK | MNTSW |
|---|---|---|
| Price | $105.17 | $0.02 |
| Analyst Decision | Buy | |
| Analyst Count | 15 | 0 |
| Target Price | ★ $111.93 | N/A |
| AVG Volume (30 Days) | ★ 14.0M | N/A |
| Earning Date | 02-03-2026 | N/A |
| Dividend Yield | ★ 3.23% | N/A |
| EPS Growth | ★ 58.08 | N/A |
| EPS | ★ 7.56 | N/A |
| Revenue | ★ $64,235,000,000.00 | N/A |
| Revenue This Year | $1.98 | N/A |
| Revenue Next Year | $4.94 | N/A |
| P/E Ratio | $13.93 | ★ N/A |
| Revenue Growth | ★ 1.68 | N/A |
| 52 Week Low | $73.31 | N/A |
| 52 Week High | $107.59 | N/A |
Technical Indicators
Market Signals| Indicator | MRK | MNTSW |
|---|---|---|
| Relative Strength Index (RSI) | 63.73 | 46.84 |
| Support Level | $96.79 | $0.02 |
| Resistance Level | $107.59 | $0.03 |
| Average True Range (ATR) | 2.06 | 0.01 |
| MACD | 0.16 | -0.00 |
| Stochastic Oscillator | 77.08 | 12.95 |
Price Performance
Historical ComparisonAbout MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
About MNTSW Momentus Inc. Warrant
Momentus Inc offers in-space infrastructure services by building transfer and service vehicles that carry satellites and hosted payloads between orbits in space. It is a provider of three critical functions, in the new space economy: Space Transportation, Satellite as a Service, and In-Orbit Servicing.